Morning Report MARCH 17, 2011 Sickle Cell Disease Chronic hemolytic anemia Multiple hemoglobin variants SS SC S-beta thal One of the most common genetic diseases worldwide Geographic distribution corresponds to distribution of malaria Carrier state is protective Sickle Cell Disease Pathogenesis Substitution of valine for glutamic acid Chromosome 11 Polymerization of deoxygenated Hb Classic crescent shape Less deformable cells in the microcirculation Leads to complications Sickle Cell Disease Diagnosis NBS Decreased deaths from pneumococcal infection Isoelectric focusing Hb electrophoresis HPLC DNA analysis If diagnosed, refer by 3 months to hematology If not available, see chart Infection Spleen Functional asplenia 30% at 1y 90% at 6y Risk for encapsulated organisms Strep pneumo Prevention PCN Immunization Treatment Parenteral antibiotics for all children with fever • Ceftriaxone • Outpatient or inpatient Resistance and incomplete protection Infection Osteomyelitis Salmonella Staph aureus Presentation overlaps with VOC Cannot differentiate on imaging Diagnosis Clinical assessment Fever Leukocytosis ESR Positive cultures Infection Parvovirus B19 Most common cause of transient red cell aplasia Predilection for young erythroblasts Presentation Plentiful in children with hemolytic anemias Fever URI Fatigue Pallor Absence of scleral icterus Decrease from baseline Hb with reticulocytopenia 7-10d Treatment Transfusion Acute Splenic Sequestration Diagnosis Sudden enlargement of spleen >2g/dL decrease in Hb from baseline Reticulocytosis May also have thrombocytopenia Very rapid <3y of age in HbSS All other ages of HbS variants Treatment Volume expanders Blood transfusions Prevention Parental education Clinical signs Palpating the spleen Splenectomy ≥2 events Acute Chest Syndrome 2nd leading cause of hospital admissions 50% of SCD patients Age More common in children More severe in adults Definition Radiologic appearance of a new pulmonary infiltrate Fever Hypoxia may be present Acute Chest Syndrome Causes Infection Bacteria, viruses, mycoplasma and chlamydia Fat embolism VOC May be due to hypoventilation associated with opioids Treatment Broad-spectrum antibiotics Cephalosporin Macrolide Oxygen Hydration Incentive spirometry Early transfusion Exchange if severe Cerebrovascular Disease Stroke 11% of SS patients <20y 22% silent infarcts Peak incidence 2-10 Path Large-arteries Internal carotid Anterior and middle cerebral Ischemic or thrombotic in 75% (predominately children) Cerebrovascular Disease Prevention TCD Detecting children at risk Flow velocity >200cm/sec Screening recommended in all children between 2-16y Chronic transfusion therapy HbS <30% Prevents second stroke in 80% Reduces stroke risk 10 fold for patients with at risk TCDs VOC Pain Crises Most distressing symptom Spectrum is wide 34% ≤ 1/year 5% multiple events Frequent admissions <6y is a known RF for death Triggers Infection Temperature extremes Dehydration Emotional stress VOC Pain Crises Treatment Multidisciplinary Aggressive pain management Opioids NSAIDs Hydration PT Ancillary therapy Avg hospital stay 4d If >10d, must wean opioids Prognosis Life expectancy SS 45y Was 14.3y just 30 years ago SC 65y